baber/WOPTO huggingface dataset:
Patent FI-944961-A0 (FI)
Inventor: POSTI JUHANI
IPC: A61K47/32
Filed: 1994-10-21
Abstract: A pharmaceutical prepn. for oral use comprises, as active agent, dichloromethylene bisphosphonic acid (clodronate) (I) or a pharmacologically acceptable salt, the prepn. being enteric coated with a film which dissolves at pH 5-7.2.
Patent FI-952566-A0 (FI)
Inventor: PETERSSON JAN
IPC: A61M13/00
Filed: 1995-05-26
Abstract: PCT No. PCT/SE93/01007 Sec. 371 Date May 23, 1995 Sec. 102(e) Date May 23, 1995 PCT Filed Nov. 23, 1993 PCT Pub. No. WO94/12230 PCT Pub. Date Jun. 9, 1994A multiple dose inhaler for the inhalation of a dry powder medicament is provided. The inhaler includes (a) a housing defining an inlet, an outlet spaced from the inlet, and an airflow path from the inlet to the outlet; (b) an elongate carrier disposed within the housing, a first portion of which carries discrete doses of the medicament, the doses being spaced from one another at predetermined substantially equidistant intervals along the length of the elongate carrier; (c) a dispensing wheel upon which the first portion of the carrier is wound; (d) a take-up wheel constructed to incrementally receive the elongate carrier from the dispensing wheel as it is unwound therefrom during use; (e) an advancement mechanism constructed to incrementally advance the elongate carrier within the housing from the dispensing wheel to the take-up wheel when the inhaler is actuated for use; (f) a brake constructed to releasably resist further advancement of the elongate carrier by the advancement mechanism after the elongate carrier has advanced an incremental distance substantially equal to the predetermined distance between the discrete doses; and (g) a trigger constructed to engage and release the brake, allowing further advancement of the elongate carrier.
Patent FI-953362-A0 (FI)
Inventor: LEUDOLPH JUERGEN
IPC: C25C7/02
Filed: 1995-07-07
Abstract: PCT No. PCT/CH94/00217 Sec. 371 Date Nov. 13, 1995 Sec. 102(e) Date Nov. 13, 1995 PCT Filed Nov. 8, 1994 PCT Pub. No. WO95/13408 PCT Pub. Date May 18, 1995A device for the electrolytic separation of metals in a metal recovery cell has a rotating cathode system. The rotating cathode includes a supporting cylinder with at least one slit, at least one sheathed cathode, contact elements, and a drive shaft provided with a current supply. The device allows simple manipulation of the supporting cylinder with the sheathed cathode and allows the user to choose the choice of material for the sheathed cathode, since this material can be matched as closely as possible to the particular process in question. The process may be used for extracting metals from electrically conductive, metal-containing solutions for recycling purposes.
Patent FI-962140-A0 (FI)
Inventor: PIIRAINEN OLLI
IPC: H04B1/10
Filed: 1996-05-21
Abstract: A method for estimating an impulse response and a receiver in a radio system where the signal to be sent comprises a known training sequence, which receiver comprises means for sampling the received signal, and means for calculating a first estimate for the impulse response by means of the known training sequence. To enable an accurate determination of impulse response, the receiver comprises means for making preliminary decisions of the received samples by means of the first impulse response estimate, means for calculating an error value of the estimated samples and the received samples calculated by means of the preliminary decisions, means for calculating a second estimate of the impulse response by minimizing said error value, and means for calculating a new estimate for the impulse response by combining the first and second estimates to one another.
Patent FI-963413-A0 (FI)
Inventor: YORDAN JORGE L
IPC: C04B33/18
Filed: 1996-09-02
Abstract: A high solids structured kaolin clay slurry having improved high shear rheology is manufactured by a process which comprises the sequential steps of forming an aqueous composition by mixing water and a lithium-based dispersant and then mixing structured kaolin clay particles with the aqueous composition to form the desired high solids slurry.
Patent FI-970878-A0 (FI)
Inventor: DAINTON ALBERT EDWARD
IPC: B22D43/00
Filed: 1997-02-28
Abstract: PCT No. PCT/GB95/01930 Sec. 371 Date Feb. 26, 1997 Sec. 102(e) Date Feb. 26, 1997 PCT Filed Aug. 15, 1995 PCT Pub. No. WO96/07496 PCT Pub. Date Mar. 14, 1996A flow control device for the outlet of a molten metal handling vessel is provided for use towards the end of the pouring of molten metal through the outlet. The flow control device has a head portion and a tail portion with flow channels defined between the head and tail portions to reduce vortex effects in the molten metal, the tail portion being contoured to fit into a correspondingly contoured entrance to the outlet with the flow channels leading into the outlet and the device being attached to a refractory positioning device so that it can be fitted into the outlet during flow of the molten metal through the outlet. The head includes a baffle plate covering the outlet.
Patent FI-972840-A0 (FI)
Inventor: VATANEN HARRI
IPC: G06Q20/34
Filed: 1997-07-02
Abstract: A procedure for the control of applications stored in a user's subscriber identity module (SIM) in a data communication system that includes a data communication network, a terminal device connected to the data communication network and to which the subscriber identity module is connected, and an application control server that is connected to the data communication network. The subscriber identity module contains a stored application that makes use of the data communication network and that is used by way of the terminal device. A key list comprising one or more application-specific keys is stored in the user's subscriber identity module, and a corresponding key list is also stored in the application control server which is operable to control applications stored in the subscriber identity modules of multiple users of the network. The application stored in the user's subscriber identity module is activated and/or closed through the transmission, verification and use of keys stored in the key lists at the subscriber identity module and at the application control server.
Patent IL-95275-A0 (IL)
Title: Oxadiazolyl-phenoxyalkylisoxazoles,their preparation and pharmaceutical compositions containing them
IPC: A61K31/4245
Filed: 1990-08-03
Abstract: Compounds of the formulas <CHEM>  wherein:  Y is an alkylene bridge of 3-9 carbon atoms;  R min  is lower-alkyl or hydroxy-lower-alkyl of 1-5 carbon atoms; R1 and R2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; and R8 is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when R8 is hydrogen R min  is hydroxy-lower-alkyl, are useful as antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.
Patent FI-20011971-A0 (FI)
Inventor: BYGGMAESTAR KLAS
IPC: F21V19/00
Filed: 2001-10-10
Abstract: The invention relates to a holder (2) for a bulb (1), whereby the bulb is connected to a reflector (3) for example for vehicular lamps and wherein the reflector has its rear provided with brackets (4) of such a design that a cap flange (5) of the bulb, and recesses present therein, fit in the brackets in such a way that the bulb sets in its position. The brackets (4) are provided with opposing lips (6), against which the cap flange (5) sets and is securable to the lips by means of U-shaped gripping jaws (7) of the holder. <IMAGE>
Patent IL-101953-A0 (IL)
Title: The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery and pharmaceutical compositions containing this compound
IPC: A61K31/522
Filed: 1992-05-21
Abstract: The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine or of physiologically tolerated salts of this compound for the production of pharmaceuticals for the prophylaxis and treatment of nerve damage after interruption of the blood circulation.
Patent IL-114760-A0 (IL)
Title: Division from 100858 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes and intermediates thereto
IPC: C07D261/12
Filed: 1995-07-27
Abstract: Isoxazole derivs. of formula (I) and their acid-addn. salts and solvates are new: In (I) R = 1-4C alkyl, allyl or cyclopropylmethyl; R1 = H, 1-4C alkyl, allyl, cyclopropylmethyl or aryl(1-4C)alkyl; X = CH2 or O; y = 4-R2-5-R3-3-isoxazolyl or 3-R2-4-R3-5-isoxazolyl; R2 and R3 = H, 1-4C alkyl, 1-4C alkoxy, 1-4C alkylthio, OH, NH2, CN or Ph. Pref. x = CH2; R and R1 = 1-4C alkyl, esp. n-Pr; R2 and R3 = H.
Patent IL-122958-A0 (IL)
Title: Method of identifying a calcimimetic compound
IPC: C07C211/26
Filed: 1998-01-16
Abstract: Method and composition useful for treating a patient having a disease characterized by an abnormal level of one or more components, the activity of which is regulated or affected by activity of one or more Ca<sup>2+</sup> receptors. Novel compounds useful in these methods and compositions are also provided. The method includes administering to the patient a therapeutically effective amount of a molecule active at one or more Ca<sup>2+</sup> receptors as an agonist or antagonist. Preferably, the molecule is able to act as either a selective agonist or antagonist at a Ca<sup>2+</sup> receptor of one or more but not all cells chosen from the group consisting of parathyroid cells, bone osteoclasts, juxtaglomerular kidney cells, proximal tubule kidney cells, keratinocytes, parafollicular thyroid cells and placental throphoblasts and a pharmaceutically acceptable carrier.
Patent IL-124742-A0 (IL)
Title: Compositions comprising a bismuth compound for the prevention and treatment of gastrointestinal disorders
IPC: A61K33/24
Filed: 1996-11-22
Abstract: The subject invention encompasses methods for the prevention and treatment of a human or lower animal subject having a gastrointestinal disorder caused or mediated by one or more intestinal helminths comprising administering bismuth to the subject.
Patent IL-128482-A0 (IL)
Title: Method and device for continuous analysis of cardiovascular activity of a subject
IPC: A61B5/02
Filed: 1999-02-11
Abstract: A method for obtaining continuously and non-invasively one or more parameters relating to the cardiovascular system of a subject. The parameters obtainable by the method are systolic blood pressure, diastolic blood pressure, young modulus of an artery, cardiac output, relative changes in vascular resistance, and relative changes in vascular compliance. In accordance with the method, the ratio,  kappa  of the subject's blood flow velocity to the propagation speed of the subject's pulse wave is obtained continuously and non-invasively.  kappa  is then processed so as to obtain the instantaneous values of the desired parameters.
Patent IL-128569-A0 (IL)
Title: Fibroblast growth factor homologous factor S(FHFs) and methods of use
IPC: A61K38/00
Filed: 1997-08-27
Abstract: The invention provides fibroblast growth factor homologous factor (FHF) polypeptides and nucleic acid molecules that encode them. Also included in the invention are diagnostic and therapeutic methods using FHF polypeptides and nucleic acids.
Patent IL-130246-A0 (IL)
Title: Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
IPC: A61B3/14
Filed: 1997-12-11
Abstract: The use of texaphyrins for ocular diagnosis and therapy is provided, especially use of photosensitive texaphyrins for photodynamic therapy of conditions of the eye characterized by abnormal vasculature, such as macular degeneration, or pterygium, for example. The photosensitive texaphyrin may be a free-base texaphyrin or may be metallated with a diamagnetic metal. Preferably, the photosensitive texaphyrin is metallated with lutetium. Due to the dual wavelength absorption of texaphyrins, i.e., at 400-500 nm and at 700-800 nm, especially about 732 nm, as compared to porphyrins, texaphyrins are more effective and versatile for use in humans as compared to porphyrins. Texaphyrins serve as effective contrast agents in ocular angiography.
Patent IL-134788-A0 (IL)
Title: A process for preparing 2-alkyl-3-aminothiophene derivatives
IPC: C07D417/12
Filed: 2000-02-28
Abstract: A compound represented by the formula (6a), which is useful as an intermediate <CHEM> wherein R<9> represents a hydrogen atom, carboxyl group or alkoxy carbonyl group having 1 to 6 carbon atoms and R<a> represents a specific aromatic or non-aromatic heterocyclic ring.
Patent IL-140622-A0 (IL)
Title: Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
IPC: C07D213/68
Filed: 1999-07-01
Abstract: Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
Patent IL-144471-A0 (IL)
Title: Methods for generating phosphorylation site-specific immunological reagents
IPC: A01K67/027
Filed: 2000-01-25
Abstract: The present invention provides methods for generating phosphorylation site-specific immunological reagents. More specifically, a phosphopeptide mimetic is incorporated into a polypeptide in place of a phosphorylated amino acid. The polypeptide is used as antigen by standard methods to generate either monoclonal or polyclonal antibodies which cross-react with the naturally phosphorylated polypeptide. The phosphopeptide mimetic preferably contains a non-hydrolyzable linkage from the appropriate carbon atom of the amino acid residue to a phosphate group. A preferred linkage is a CF2 group. Such a linkage is used to generate the phosphoserine mimetic F2Pab, which is incorporated into a polypeptide sequence derived from p53 to produce antibodies which recognize a specific phosphorylation state of p53. A CF2 group linkage is also used to produce the phosphothreonine mimetic F2Pmb, and to produce the phosphotyrosine mimetic, F2Pmp.
Patent IL-146548-A0 (IL)
Title: Anhydrous mirtazapine and process for preparing the same
IPC: C07D471/14
Filed: 2001-11-19
Abstract: Methods for producing anhydrous mirtazapine crystals that are either (1) substantially free of lower alcohol insolubles or (2) substantially free of residual solvent and have an average particle diameter of from 10 to 50  mu m, are provided, and the resulting anhydrous mirtazapine crystals produced thereby, which are useful in pharmaceuticals.
Patent IL-149133-A0 (IL)
Title: Barrier device for covering the ostium of left atrial appendage
IPC: A61B17/122
Filed: 2000-10-23
Abstract: A membrane applied to the ostium of an atrial appendage is disclosed. The membrane prevents blood clots in the atrial appendage from escaping therefrom and entering the blood stream which can result in a blocked blood vessel, leading to strokes and heart attacks. The membrane may be permeable or impermeable with respect to blood flow. The membrane is configured to extend over the ostium of the left atrial appendage. The membrane has an outer periphery with a dimension larger than a corresponding dimension of the ostium. Securement means is provided to secure the outer periphery of the membrane in direct engagement with the atrial wall surrounding the ostium. The securement means may located between the membrane and the atrial wall, or the securement means may extend distally from the membrane through the ostium. <IMAGE>
Patent IL-152395-A0 (IL)
Title: Method for determining distances in the anterior ocular segment
IPC: A61B3/11
Filed: 2002-02-16
Abstract: The method involves acquiring and digitizing an image of at least part of the eye with an image acquisition unit and an arrangement for illuminating the eye and carrying out a coarse center of image analysis and center point determination using an intensity threshold analysis, especially for the position of the pupil, then performing fine detection of the position of the pupil and/or iris edges.
Patent IL-155236-A0 (IL)
Title: Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
IPC: A61P3/04
Filed: 2001-10-01
Abstract: The invention concerns the association of the CB1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity.
Patent IL-162448-A0 (IL)
Title: Process for the purification and/orisolation of biologically active granulocyte colony stimulating factor
IPC: A61P35/00
Filed: 2002-12-05
Abstract: The invention relates to the process for the isolation of biologically active granulocyte colony stimulating factor (G-CSF), which enables the separation of correctly folded biologically active monomeric molecules of G-CSF from the incorrectly folded, biologically inactive monomeric, oligo- or polymeric and also from aggregated molecules of G-CSF by using immobilised metal affinity chromatography. The process of the invention, if desired the whole process, can be advantageously performed under native conditions. The biologically active G-CSF with a purity of greater than 95% is thus obtained. Only two additional chromatographic steps, cationic exchange chromatography and gel filtration, are then preferably applied to remove the traces of impurities. The entire process results in the production of higher yields of G-CSF with a purity of greater than 99%. The described process is particularly suitable for the industrial production of G-CSF.
Patent IL-169136-A0 (IL)
Title: Improved memory management for real-time applications
IPC: G06F12/12
Filed: 2005-06-14
Abstract: Memory management in a computer system is improved by preventing a subset of address translation information from being replaced with other types of address translation information in a cache memory reserved for storing such address translation information for faster access by a CPU. This way, the CPU can identify the subset of address translation information stored in the cache.
Patent IL-179979-A0 (IL)
Title: Asymmetrically substituted biaryldiphosphine ligands 11
IPC: C07F9/50
Filed: 2006-12-11
Abstract: A process for the preparation of asymmetrically substituted biaryldiphosphine ligands of the formula: wherein R1 is C1-6-alkyl or C3-10-cycloalkyl optionally being substituted with one or more halogen atoms, and R2 and R3 are equal and are C5-10-cycloalkyl and C1-6-alkyl, or R2 is C5-10-cycloalkyl or C1-6-alkyl, and R3 is aryl optionally substituted with one or more substituents selected from the group consisting of halogen atoms, nitro, amino, C1-6-alkyl, C1-6-akoxy and di-C1-6-alkylamino groups,2 and each C1-6-alkyl, C1-6-alkoxy, di-C1-6-alkylamino and C5-10-cycloalkyl group in R2 and R3 is optionally substituted with one or more halogen atoms, from 2,2',6,6'-tetrabromobiphenyl by a sequence of bromine-metal exchanges and subsequent reactions.
Patent IL-185295-A0 (IL)
Title: Rapid tooling system and methods for manufacturing abrasive articles
Filed: 2007-08-15
Abstract: A rapid structuring media cartridge includes a cartridge body, a first binder and first abrasive particles. The cartridge is operable to deposit successive patterned layers including the first binder and first abrasive particles to form an abrasive structure.
Patent IL-195912-A0 (IL)
Title: Benzimidazoles and their use for the treatment of diabetes
Filed: 2008-12-14
Abstract: Compounds of formula (I), or salts thereof, which inhibit acetyl CoA (acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, wherein: R1 is selected from optionally substituted phenyl, cyclopentyl, cyclohexyl and 5- or 6-membered heteroaryl; L1 is a direct bond or a linker selected from, for example, -O-, -OCH2- and -CH2O-; R2 is selected from, for example, (3-6C)cycloalkyl, (5-12C)bicycloalkyl, phenyl and a 4, 5- or 6-membered saturated, partially or fully unsaturated heterocyclyl ring; wherein R2 is substituted by defined substituents and R6 is selected from, for example, hydrogen, fluoro and chloro; together with processes for their preparation, pharmaceutical compositions containing them and their use as medicaments.
Patent IL-200897-A0 (IL)
Title: Insect attractant
Filed: 2009-09-13
Abstract: The invention relates to insect attractants containing compounds with pentagonal heterocyclic structures that are effective in attracting fruitflies.
Patent RO-125945-A0 (RO)
Title: System for the supply of led modules with inductive ballast
Inventor: SCHEUSAN EUGEN
IPC: H05B39/02
Filed: 2010-02-02
Abstract: The invention relates to a system for A.C. supply of LEDs or LED modules. According to the invention, the system allows LED supply from a A.C. source by means of an inductive ballast (L), a rectifier (V) and two capacitors (Cand C), the first condenser being mounted on the mains connection terminals and the other one being mounted between the rectifier (V) and the LEDs.
Patent RO-126946-A0 (RO)
Title: Tubular briquette made of ferrous wastes as powder and smalls
Inventor: HEPUŢ TEODOR
IPC: C22B1/248
Filed: 2010-05-17
Abstract: The invention relates to a tubular briquette made of ferrous wastes as powder and smalls, meant to be used in the ferrous metallurgy, in reduction equipments, such as in pig-iron furnaces or in installations for the direct iron reduction from ores, with a view to obtaining iron sponge. According to the invention, the briquette () is tube-shaped, having an external diameter D = 60...70 mm, an internal diameter d = 20...25 mm, the height h = 40...45 mm and having an external cylindrical surface (), an internal cylindrical surface (), two flat surfaces () equal to each other, a cavity (), and is obtained by the compression of a mixture in a mould, using a hydraulic press, the mixture comprising 40...60% steel foundry dust, 8...12% blast-furnace dust, 8...12% blast-furnace agglomeration slag, 5...9% iron scale, 5...8% coal dust, 5...8% the ferrous fraction of the steel foundry slag, 3...5% graphite, 2...4% bentonite, 2...4% lime and 4...8% water.
Patent RO-129358-A0 (RO)
Title: Unmanned mini flying apparatus
Inventor: POPP EMANUEL
IPC: B64C15/00
Filed: 2013-11-05
Abstract: The invention relates to an unmanned mini flying apparatus, which can perform pre-programmed missions, being destined to survey specific areas, borders presenting a risk of illegal traffic, zones of calamities as a consequence of natural and anthropic disasters, critical infrastructure, the missions consisting in picking up information, transmitting video images, data about gas emissions, radiations, or in collecting data and information about the enemy in case of military operations. According to the invention, the mini apparatus has a modular construction consisting of some wings (WG), some winglets (WGT), a fuselage (FSL), a front module (MF), a rear module (MP), a longeron (LJ), a payload (SU), the front module and the rear module (MF and MP), respectively, containing the storage batteries for the propulsion and for supplying the other equipments on-board and additionally the rear module (MP) contains the propulsion motor, the component elements including the payload (SU) being easily snap-fit mounted, without using delicate tools, the dismounting implying the usage of a simple wedge-type device.